Related Experiment Video
Updated: Jun 5, 2026
09:29
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Preclinical drug development
Teresa Brodniewicz1, Grzegorz Grynkiewicz
1MTZ Clinical Research, Pawińskiego 5, 02-106 Warszawa, Poland.
Acta Poloniae Pharmaceutica
|January 15, 2011
Summary
Drug discovery faces high costs and inefficiency, with many candidates failing before launch. This paper outlines essential preclinical drug development rules for new chemical entities to improve success rates.
Area of Science:
- Life sciences
- Drug discovery and development
- Pharmaceutical innovation
Background:
- Current drug discovery is lengthy, costly, and inefficient, with high attrition rates.
- Innovation is crucial, driving increased research outside large pharmaceutical companies.
- Project management requires expertise in scientific, technical, and legal aspects.
Purpose of the Study:
- To explain basic rules and requirements for drug development.
- Focuses on the preclinical study period.
- Covers new chemical entities of natural or synthetic origin (low molecular weight).
Main Methods:
- Review of scientific principles in drug design.
- Analysis of the drug discovery and development process.
- Examination of regulatory requirements for preclinical studies.
Main Results:
- Identified inefficiencies and high costs in the current drug development pipeline.
- Highlighted the critical role of project management in academic and small company settings.
- Detailed the preclinical study requirements for low molecular weight new chemical entities.
Conclusions:
- Preclinical study requirements are essential for successful drug development.
- Effective project management integrating scientific, technical, and legal knowledge is key.
- Understanding these rules can improve the efficiency of bringing new drugs to market.
Related Concept Videos
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...